Literature DB >> 26375999

Data mining The Cancer Genome Atlas in the era of precision cancer medicine.

Phil F Cheng1, Reinhard Dummer1, Mitchell P Levesque1.   

Abstract

The Cancer Genome Atlas (TCGA) has given researchers and clinicians unprecedented access to many different cancers through multiple platforms that include exome sequencing, comparative genomic hybridisation (CGH) arrays, DNA methylation arrays, RNA sequencing, reverse protein phase arrays (RPPA), and clinical features. Most data are available to the public in their raw and processed forms; however, analysis and interpretation of these data require specialised training and software. To address this problem, online tools such as cBioportal, canEvolve, GDAC firehose, PROGgeneV2, and UCSC Cancer browser have been developed by various groups to explore and perform analyses on the datasets that are easily understandable by basic researchers and clinicians. In this mini-review, we give an overview of the datasets available from TCGA and the public tools available for integrative analysis of survival with the genomic and transcriptomic datasets, and introduce a tool being developed by our group to analyse the datasets within TCGA.

Entities:  

Mesh:

Year:  2015        PMID: 26375999     DOI: 10.4414/smw.2015.14183

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  24 in total

1.  GlioVis data portal for visualization and analysis of brain tumor expression datasets.

Authors:  Robert L Bowman; Qianghu Wang; Angel Carro; Roel G W Verhaak; Massimo Squatrito
Journal:  Neuro Oncol       Date:  2016-11-09       Impact factor: 12.300

2.  Diagnostic and prognostic value of FOXD1 expression in head and neck squamous cell carcinoma.

Authors:  Shijie Qiu; Dan Li; Zhisen Shen; Qun Li; Yi Shen; Hongxia Deng; Yidong Wu; Chongchang Zhou
Journal:  J Cancer       Date:  2021-01-01       Impact factor: 4.207

3.  A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments.

Authors:  Kevin C Barry; Joy Hsu; Miranda L Broz; Francisco J Cueto; Mikhail Binnewies; Alexis J Combes; Amanda E Nelson; Kimberly Loo; Raj Kumar; Michael D Rosenblum; Michael D Alvarado; Denise M Wolf; Dusan Bogunovic; Nina Bhardwaj; Adil I Daud; Patrick K Ha; William R Ryan; Joshua L Pollack; Bushra Samad; Saurabh Asthana; Vincent Chan; Matthew F Krummel
Journal:  Nat Med       Date:  2018-06-25       Impact factor: 53.440

4.  Comparative oncogenomics identifies tyrosine kinase FES as a tumor suppressor in melanoma.

Authors:  Michael Olvedy; Julie C Tisserand; Flavie Luciani; Bram Boeckx; Jasper Wouters; Sophie Lopez; Florian Rambow; Sara Aibar; Bernard Thienpont; Jasmine Barra; Corinna Köhler; Enrico Radaelli; Sophie Tartare-Deckert; Stein Aerts; Patrice Dubreuil; Joost J van den Oord; Diether Lambrechts; Paulo De Sepulveda; Jean-Christophe Marine
Journal:  J Clin Invest       Date:  2017-05-02       Impact factor: 14.808

5.  Epitope spreading toward wild-type melanocyte-lineage antigens rescues suboptimal immune checkpoint blockade responses.

Authors:  Jennifer A Lo; Masayoshi Kawakubo; Vikram R Juneja; Mack Y Su; Tal H Erlich; Martin W LaFleur; Lajos V Kemeny; Mamunur Rashid; Mohsen Malehmir; S Alireza Rabi; Rumya Raghavan; Jennifer Allouche; Gyulnara Kasumova; Dennie T Frederick; Kristen E Pauken; Qing Yu Weng; Marcelo Pereira da Silva; Yu Xu; Anita A J van der Sande; Whitney Silkworth; Elisabeth Roider; Edward P Browne; David J Lieb; Belinda Wang; Levi A Garraway; Catherine J Wu; Keith T Flaherty; Constance E Brinckerhoff; David W Mullins; David J Adams; Nir Hacohen; Mai P Hoang; Genevieve M Boland; Gordon J Freeman; Arlene H Sharpe; Dieter Manstein; David E Fisher
Journal:  Sci Transl Med       Date:  2021-02-17       Impact factor: 17.956

Review 6.  Therapeutic potential of targeting the Eph/ephrin signaling complex.

Authors:  Nayanendu Saha; Dorothea Robev; Emilia O Mason; Juha P Himanen; Dimitar B Nikolov
Journal:  Int J Biochem Cell Biol       Date:  2018-10-19       Impact factor: 5.085

7.  Differential alternative RNA splicing and transcription events between tumors from African American and White patients in The Cancer Genome Atlas.

Authors:  Muthana Al Abo; Terry Hyslop; Xiaodi Qin; Kouros Owzar; Daniel J George; Steven R Patierno; Jennifer A Freedman
Journal:  Genomics       Date:  2021-03-08       Impact factor: 5.736

8.  Loss of cIAP1 in Endothelial Cells Limits Metastatic Extravasation through Tumor-Derived Lymphotoxin Alpha.

Authors:  Lazaros Vasilikos; Kay Hänggi; Lisanne M Spilgies; Samanta Kisele; Stefanie Rufli; W Wei-Lynn Wong
Journal:  Cancers (Basel)       Date:  2021-02-03       Impact factor: 6.639

9.  Networks Models of Actin Dynamics during Spermatozoa Postejaculatory Life: A Comparison among Human-Made and Text Mining-Based Models.

Authors:  Nicola Bernabò; Alessandra Ordinelli; Marina Ramal Sanchez; Mauro Mattioli; Barbara Barboni
Journal:  Biomed Res Int       Date:  2016-08-24       Impact factor: 3.411

10.  Mutant-allele fraction heterogeneity is associated with non-small cell lung cancer patient survival.

Authors:  Sipeng Shen; Yongyue Wei; Ruyang Zhang; Mulong Du; Weiwei Duan; Sheng Yang; Yang Zhao; David C Christiani; Feng Chen
Journal:  Oncol Lett       Date:  2017-11-15       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.